CSIC Delegation in the Region of Valencia

CSIC Delegation in the Region of Valencia

Information
Calle Bailía, 1 (Plaza de la Virgen). 46003 - València

addictions, Alzheimer's, astrophysics, bioethics, climate change, cancer, natural sciences, climate, quantum computing, pollution, covid-19, embryonic development, diabetes, gene editing, education, energy, cardiovascular diseases, neurodegenerative diseases, rare diseases, ageing, epidemiology, STDs, physics, immunology, artificial intelligence, language, microbiology, nanoscience, neuroscience, new materials, chemistry, mental health, AIDS / HIV, sociology, supercomputing, transgenics
Contact
Isidoro García Cano
Head of Communication
isidoro.garcia@dicv.csic.es
+34 96 362 27 57
Sergio Villalba Lapeña
R+D+i Technician
g.prensa@dicv.csic.es
+34 96 362 27 57

If you are the contact person for this centre and you wish to make any changes, please contact us.

SMC participants

Director of the Institute of Neurosciences, a joint centre of the Miguel Hernández University of Elche (UMH) and the CSIC

Researcher at the Institute of Molecular and Cellular Biology of Plants (UPV-CSIC)

Researcher at the Climate, Atmosphere and Oceans Laboratory (Climatoc-Lab) at the Desertification Research Centre (CIDE, CSIC-UV-GVA)

Senior Scientist in Social Sciences at INGENIO (CSIC-UPV)

CIDEGENT Distinguished Researcher

Researcher, Instituto de Física Corpuscular 

Professor of the Department of Theoretical Physics & IFIC of the University of Valencia - CSIC

Coordinator of the CSIC Global Health Platform and researcher at the Instituto de Biomedicina de Valencia (IBV-CSIC)

CSIC Group Leader at the Institute of Neurosciences (CSIC-UMH)

Full CSIC scientist at the Institute of Biomedicine of Valencia (CSIC-CIBERNED)

Contents related to this centre
SARS-CoV-2

The UK Health Security Agency published in its latest report on 25 March the detection of three recombinant forms of omicron, called XE, XD and XF. The WHO mentions them in its 29 March report, noting that the possibility that XE is more transmissible than BA.2 still requires further study.

BA.2 Omicron variant

The WHO recommends keeping an eye on the BA.2 variant of Omicron because it is spreading, but it does not appear to cause more serious disease or escape vaccination. Don't be fooled by its evocative nickname: it is perfectly detectable. The misconception that tests do not identify it was propagated by a headline that was corrected.

PCR

A new variant of the coronavirus causing COVID-19 has been identified in South Africa, with numerous mutations present in other variants, including Delta. Variant B.1.1.529, as it is now called, appears to be spreading rapidly in South Africa. Attached is the rapid reaction of three Spanish researchers with expertise in genomic surveillance.